Partner Investment Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-14,720
Closed -$768K 76
2019
Q3
$768K Sell
14,720
-2,552
-15% -$136K 1.32% 30
2019
Q2
$866K Buy
17,272
+1,910
+12% +$93K 0.92% 42
2019
Q1
$799K Sell
15,362
-1,261
-8% -$58.1K 0.92% 41
2018
Q4
$812K Sell
16,623
-4,135
-20% -$228K 1.01% 36
2018
Q3
$1.35M Sell
20,758
-1,673
-7% -$98.4K 1.04% 38
2018
Q2
$1.11M Buy
22,431
+9,760
+77% +$473K 0.9% 44
2018
Q1
$618K Sell
12,671
-5,830
-32% -$303K 0.67% 52
2017
Q4
$779K Sell
18,501
-4,236
-19% -$163K 0.9% 43
2017
Q3
$974K Sell
22,737
-4,633
-17% -$148K 0.92% 39
2017
Q2
$359K Sell
27,370
-3,587
-12% -$47.3K 0.48% 59
2017
Q1
$407K Sell
30,957
-1,539
-5% -$19.7K 0.5% 66
2016
Q4
$421K Buy
32,496
+6,998
+27% +$108K 0.56% 60
2016
Q3
$417K Buy
25,498
+9,311
+58% +$168K 0.62% 56
2016
Q2
$201K Buy
16,187
+687
+4% +$8.59K 0.33% 69
2016
Q1
$166K Sell
15,500
-103
-0.7% -$937 0.27% 69
2015
Q4
$229K Buy
+15,603
New +$191K 0.38% 55

Other funds holding MYOK

Partner Investment Management's MYOK Position: Q4 2019 in Review

Partner Investment Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2019, closing a stake of 14,720 shares — an estimated $768K sold.

Partner Investment Management first reported a position in MYOK in Q4 2015 and held it in 16 quarters. The position peaked at $1.35M in Q3 2018. 178 funds tracked by Wall St. Rank hold MYOK as of Q4 2019.

  • Partner Investment Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Partner Investment Management sold 14,720 MyoKardia, Inc. Common Stock shares in Q4 2019, an estimated $768K.
  • Partner Investment Management first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 16 quarters.
  • Partner Investment Management's MyoKardia, Inc. Common Stock position peaked at $1.35M in Q3 2018.
  • 178 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.